US-based device company Nevro has secured market authorisation from the European Union (EU) for its HFX iQ spinal cord ...

The global spinal cord stimulators market is on a robust growth trajectory, poised to reach an impressive valuation of USD 5,441.4 million by 2033. Currently valued at USD 2,702.7 million in 2023, the ...

Inceptiv is a small device, implanted in the lower torso with leads to the spinal cord, that provides responsive counter-stimulation to relieve chronic pain. The device was approved by the FDA in ...

Spinal cord compression—also called cervical spondylotic myelopathy (CSM)— is caused by any condition that puts pressure on the spinal cord. Symptoms may develop suddenly or gradually and may include ...

The investment, announced Oct. 24, makes Ottoback (Duderstadt Germany) the largest shareholder in Onward Medical (Eindhoven, The Netherlands).

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Surgery, including a surgical nerve block, is rarely used to treat arachnoiditis due to high failure rates. However, newer techniques like spinal cord stimulation (SCS) are demonstrating positive ...

Spinal cord compression (SCC) occurs in 5% to 30% of the oncology population and affects patient function, comfort, and general quality of life. Patients with lung cancer, breast cancer ...